Bidaible's platform reduces construction bid management time while improving accuracy and providing actionable ...
NEW YORK CITY, NEW YORK / ACCESS Newswire / January 7, 2026 / Emerging Growth Research today announced the release of ...
Richard Francis, Teva's President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 A.M. Pacific Time (11:15 A.M. Eastern Time)TEL AVIV, ...
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million to support Teva's anti-IL-15 candidate TEV-'408TEV-' ...